OPKO Health, Inc. (OPK) has a MoatMap StockRank of 51/100 based on Quality (35/100), Value (50/100), and Momentum (52/100) factor scores. The current signal is HOLD. OPKO Health has a history of capital destruction and low quality metrics (Q: 34). It fails our fundamental quality screens.
OPKO Health, Inc. is a diversified healthcare company operating through two main segments: diagnostics, including clinical laboratory services and molecular diagnostics, and pharmaceuticals, focused on specialty drugs and clinical development. The company seeks to leverage proprietary technologies like 4Kscore and RAYALDEE within its integrated model to address significant medical needs. OPKO aims to combine diagnostic insights with therapeutic innovation to provide comprehensive patient solutions globally.
| Price | $1.43 |
| Market Cap | $1.1B |
| P/E (Forward) | -4.56 |
| Price/Book | 0.87 |
| Return on Equity | -16.9% |
| Return on Invested Capital | -7.4% |
| Debt/Equity | 32.95 |
| Gross Margin | 14.9% |
| Operating Margin | -41.1% |
| Revenue Growth | -17.2% |
| Free Cash Flow | $-36M |
OPKO Health, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).